JUNE 1, 2025
Please join us for an exclusive sneak peek of the forthcoming documentary
Cracking the Code: Phil Sharp and the Biotech Revolution
adjacent to the 2025 ASCO Annual Meeting.
Not an official event of the 2025 ASCO Annual Meeting Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer® the ASCO Foundation. Not CME-accredited.
Cracking the Code is a powerful reminder that breakthroughs and life-saving biotech treatments don’t happen by accident. They happen because of a unique ecosystem—one that supports bold ideas, invests in basic research, and encourages entrepreneurs to take risks. The market plays a critical role in this ecosystem, turning scientific discoveries into real-world solutions that improve lives and drive economic growth. Phil Sharp’s journey—from groundbreaking research to founding transformative companies like Biogen and Alnylam—shows how science, entrepreneurship, and the market can work together to solve humanity’s greatest challenges.
June 1, 2025
6:30 – Screening followed by a discussion
with director Bill Haney and a networking reception
Hyatt Regency McCormick Place
2233 S Martin Luther King Dr, Chicago, IL 60616
About Phil Sharp
Phillip A. Sharp, PhD, an Institute Professor emeritus at MIT, is a member of the Department of Biology and the Koch Institute for Integrative Cancer Research. His work studying the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing earned Sharp the 1993 Nobel Prize in Physiology for Medicine. Sharp is past President of AAAS, serves on the boards of directors of the Broad Institute, Stand Up 2 Cancer, and the Gairdner Foundation. He is a co-founder of Biogen and of Alnylam Pharmaceuticals and serves on the Scientific Advisory Boards of F-Prime Capital, Alnylam Pharmaceuticals, Danaher, Dewpoint Therapeutics, and Skyhawk Therapeutics, He is also advisor to Longwood and Polaris Venture Funds.
About the Director
Bill Haney is a filmmaker, inventor, and entrepreneur. His most recent film projects include Cracking the Code: Phil Sharp and the Biotech Revolution, and Jim Allison: Breakthrough. He has started more than a dozen companies and is currently the Co-founder and CEO of Dragonfly Therapeutics, a clinical stage biotech focused on novel NK-cell based immune engagers, and Co-founder & Chairman of Skyhawk Therapeutics, a clinical stage biotech focused on small molecule RNA splicing modifiers. Bill is a graduate of Harvard College and served as a Fellow of Harvard's Kennedy School.​
ABOUT THE FILM
Cracking the Code, narrated by Mark Ruffalo, is an inspiring story of vision, perseverance, and the power of science to change the world. Phil Sharp’s journey from a Kentucky farm boy to Nobel laureate embodies the American Dream and the triumph of entrepreneurial spirit. His 1977 groundbreaking discovery of RNA splicing rewrote the rules of molecular biology and ignited a life-saving scientific revolution, laying the foundation for an industry that has become a cornerstone of global innovation and economic growth – and transformed the health of billions of patients worldwide.
